Drug Profile
Research programme: farnesoid X-activated receptor agonists - Chia Tai Tianqing Pharmaceutical Group
Alternative Names: WXS 005Latest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator Chia Tai Tianqing Pharmaceutical Group
- Class Bile acids and salts; Hepatoprotectants
- Mechanism of Action Farnesoid X-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis; Primary biliary cirrhosis
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in China (PO)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Primary-biliary-cirrhosis in China (PO)
- 20 Oct 2017 Preclinical trials in Non-alcoholic steatohepatitis in China (PO)